Serum Institute of India (SII), the world's biggest vaccine maker, has already stockpiled more than 50 million doses of the AstraZeneca shot, even as it awaits emergency-use approvals from both British and Indian authorities. Pharmaceutical packager Schott Kaisha, meanwhile, is stepping up production of vaccine vials and Deutsche Post's DHL is working out how best to distribute the shots within the country and around the world. But much of India's vaccine production could be, at least initially, for domestic use. The company's ongoing expansion will nevertheless double its vaccine handling capacity to 200 million doses by March. For DHL, the world's largest courier and logistics company, vaccine transportation work has already begun in India.

Source: bd News24 December 10, 2020 16:18 UTC